| Entry |
|
|---|
| Name |
Reglitazar (JAN/INN) |
|---|
| Formula |
C22H20N2O5
|
|---|
| Exact mass |
392.1372
|
|---|
| Mol weight |
392.4046
|
|---|
| Structure |
|
|---|
| Class |
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01732 Non-thiazolidinedione type PPAR agonist
|
|---|
| Efficacy |
Antidiabetic, Hypoglycemic, Peroxisome proliferator-activated receptor (PPAR) gamma agonist |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01732 Non-thiazolidinedione type PPAR agonist
D01971 Reglitazar
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C3 (PPARG)
D01971 Reglitazar (JAN/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 29
1 O2a O 32.6340 -18.1511
2 C8y C 33.8945 -17.4508
3 C8x C 35.0851 -18.1511
4 C8x C 36.3456 -17.5209
5 C8y C 36.3456 -16.1202
6 C8x C 35.1551 -15.3498
7 C8x C 33.8945 -16.0501
8 C1b C 37.5362 -15.4198
9 C1y C 38.7968 -16.1202
10 O2x O 27.2416 -16.1202
11 C8y C 28.6421 -16.1202
12 C8y C 28.9924 -17.4508
13 N5x N 27.9419 -18.2911
14 C8y C 26.8213 -17.4508
15 C1b C 31.3734 -17.4508
16 C1b C 30.1829 -18.1511
17 C1a C 29.4125 -14.9997
18 C8x C 23.1797 -19.4817
19 C8x C 23.1797 -18.1511
20 C8x C 24.3703 -17.4508
21 C8y C 25.6309 -18.1511
22 C8x C 25.6309 -19.4817
23 C8x C 24.3703 -20.1820
24 C5x C 38.7879 -17.5418
25 N1x N 40.1362 -17.9864
26 O7x O 40.9757 -16.8414
27 C7x C 40.1462 -15.6893
28 O6a O 40.5814 -14.3693
29 O5x O 37.6329 -18.3736
BOND 32
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 2
5 5 6 1
6 6 7 2
7 2 7 1
8 5 8 1
9 8 9 1
10 10 11 1
11 11 12 2
12 12 13 1
13 13 14 2
14 10 14 1
15 1 15 1
16 15 16 1
17 16 12 1
18 11 17 1
19 18 19 1
20 19 20 2
21 20 21 1
22 21 22 2
23 22 23 1
24 18 23 2
25 21 14 1
26 9 24 1
27 24 25 1
28 25 26 1
29 26 27 1
30 9 27 1
31 27 28 2
32 24 29 2
|
|---|
